Trevor Angell is an Endocrinology/Metabolic physician affiliated with University of Southern California. OpenAlex indexes 175 publications with 3,787 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1520 San Pablo St Ste 1000
Los Angeles, CA 90033
Telephone
323-442-5100Provider last certified this registry record 29 Sept 2020.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- ABBVIE INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
64.5%l-Thyroxine56.7%Levothyroxine Sodium76%Synthroid24%Part D≥75 patientsThyroid Hormone Synthesis Inhibitor7.8%Methimazole100%Part D≥15 patientsMetabolism & gastrointestinal
29.9%Insulin Analog8.9%Basaglar Kwikpen U-10040%Lantus Solostar38%Humalog23%Part D<11 patientsSGLT2 inhibitor5.9%Jardiance100%Part D<11 patients+ 4 more classes in this area
Sensory organs
3.2%Corticosteroid3.2%Hydrocortisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci
JAMA Otolaryngology–Head & Neck Surgery
2024 - Clonally expanded, thyrotoxic effector CD8 <sup>+</sup> T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis
Science Translational Medicine
2023 - Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis
The Journal of Clinical Endocrinology & Metabolism
2022
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”